A Cleveland Clinic researcher has been awarded a $720,000 federal grant to test two approaches to improving chronic kidney disease care and outcomes.
Dr. Joseph Nally Jr., director of the Clinic’s Center for Chronic Kidney Disease, received the three-year grant from the National Institutes of Health, according to a statement from the Clinic.
“Current treatments are effective in slowing the progression of chronic kidney disease, but inadequate awareness among patients and providers has limited the widespread application of these treatments,” Nally said.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
The first clinical trial in the study will pair patients with nonclinical professionals who are trained to identify issues and barriers during the care process — such as insurance or transportation to appointments.
The second will test enhancements to electronic health records designed to assist healthcare providers in identifying and following patients who show signs of deteriorating kidney function.
Diabetes and high blood pressure are the two most common causes of chronic kidney disease and account for most cases.